Back

Insights into pulmonary remodelling in heart failure with preserved ejection fraction through transpulmonary biomarker gradients

31 August 2025 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: HFpEF issues Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Misha Dagan

Heart Centre at The Alfred, Melbourne (Australia)

5 More presentations in this session

Presentation thumbnail
Small left ventricle in patients with heart failure with preserved ejection fraction is associated with higher mortality
Doctor Y. Nakagawa (Kawanishi, JP)
Abstract Slides Video
Presentation thumbnail
Phenogrouping HFpEF trajectories identifies early and end-stage subtypes: a multicentre study using natural language processing
Doctor S. Brown (London, GB)
Abstract Slides Video
Presentation thumbnail
Gender-specific outcomes and treatment responses in elderly HFpEF patients: a comprehensive single-center retrospective study
Doctor K. Shi (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
Dapagliflozin versus empagliflozin in patients with heart failure with preserved ejection fraction
Doctor J. Kassab (Dallas, US)
Abstract Slides Video
Presentation thumbnail
Characteristics of pulmonary hypertension in adults with left ventricular diastolic dysfunction
Doctor S. Ratwatte (London, GB)
Abstract Slides Video

Access the full session

Session thumbnail
HFpEF issues

The Event

Event poster

ESC Congress 2025

31 August 2025 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Transpulmonary proteome gradients identify inflammatory pathways involved in the development of pulmonary vasculopathy in heart failure
thumbnail
Congress Presentation
Left atrial remodeling and novel biomarkers in obese patients with heart failure with preserved ejection fraction compared to type-2-diabetics and obese controls: a cardiac magnetic resonance study
thumbnail
Congress Session
HFpEF: mechanisms and translational perspectives

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources